Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
31.00
-1.12 (-3.49%)
At close: Feb 21, 2025, 4:00 PM
31.04
+0.04 (0.13%)
After-hours: Feb 21, 2025, 4:57 PM EST
Tandem Diabetes Care Analyst Ratings
Total Analysts
15
Consensus Rating
Strong Buy
Price Target
$53.93
Upside
+73.97%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $57 → $50 | Strong Buy | Maintains | $57 → $50 | +61.29% | Dec 11, 2024 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $45 | Hold → Buy | Upgrades | $45 | +45.16% | Dec 2, 2024 |
| Barclays | Barclays | Buy Maintains $58 → $60 | Buy | Maintains | $58 → $60 | +93.55% | Nov 8, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $57 → $56 | Strong Buy | Maintains | $57 → $56 | +80.65% | Nov 7, 2024 |
| Baird | Baird | Hold Maintains $39 → $37 | Hold | Maintains | $39 → $37 | +19.35% | Nov 7, 2024 |
| Bernstein | Bernstein | Buy Initiates $42 | Buy | Initiates | $42 | +35.48% | Nov 6, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $46 | Hold | Initiates | $46 | +48.39% | Oct 4, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $65 | Buy | Initiates | $65 | +109.68% | Oct 2, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $45 | Hold | Maintains | $45 | +45.16% | Sep 23, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $45 | Hold | Initiates | $45 | +45.16% | Aug 22, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $57 | Strong Buy | Initiates | $57 | +83.87% | Aug 8, 2024 |
| Barclays | Barclays | Buy Maintains $55 → $58 | Buy | Maintains | $55 → $58 | +87.10% | Aug 5, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $50 → $55 | Buy | Maintains | $50 → $55 | +77.42% | Aug 2, 2024 |
| Baird | Baird | Hold Maintains $36 → $39 | Hold | Maintains | $36 → $39 | +25.81% | Aug 2, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $50 → $55 | Buy | Reiterates | $50 → $55 | +77.42% | Aug 2, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $47 → $58 | Buy | Maintains | $47 → $58 | +87.10% | Jun 10, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.